Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure

Por Bins, Sander, Eechoute, Karel, Kloth, Jacqueline S. L., de Man, Femke M., Oosten, Astrid W., de Bruijn, Peter, Sleijfer, Stefan, Mathijssen, Ron H. J.
Publicado no Clin Pharmacokinet (2016)

Influence of Drug Formulation on OATP1B-Mediated Transport of Paclitaxel

Por Nieuweboer, Annemieke J.M., Hu, Shuiying, Hagenbuch, Bruno, Moghaddam-Helmantel, Inge Ghobadi, Gibson, Alice A., de Bruijn, Peter, Mathijssen, Ron H. J., Sparreboom, Alex
Publicado em 2014

Population pharmacokinetic modelling to assess the impact of CYP2D6 and CYP3A metabolic phenotypes on the pharmacokinetics of tamoxifen and endoxifen

Por ter Heine, Rob, Binkhorst, Lisette, de Graan, Anne Joy M, de Bruijn, Peter, Beijnen, Jos H, Mathijssen, Ron H J, Huitema, Alwin D R
Publicado no Br J Clin Pharmacol (2014)

Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment

Por Heijns, Joan B., van der Burg, Maria E. L., van Gelder, Teun, Fieren, Marien W. J. A., de Bruijn, Peter, van der Gaast, Ate, Loos, Walter J.
Publicado em 2008

Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients

Por Oosten, Astrid W., Abrantes, João A., Jönsson, Siv, de Bruijn, Peter, Kuip, Evelien J. M., Falcão, Amílcar, van der Rijt, Carin C. D., Mathijssen, Ron H. J.
Publicado no Eur J Clin Pharmacol (2016)

Fasting protects against the side effects of irinotecan treatment but does not affect anti‐tumour activity in mice

Por Huisman, Sander A, de Bruijn, Peter, Ghobadi Moghaddam‐Helmantel, Inge M, IJzermans, Jan N M, Wiemer, Erik A C, Mathijssen, Ron H J, de Bruin, Ron W F
Publicado no Br J Pharmacol (2016)

Augmentation of Endoxifen Exposure in Tamoxifen-Treated Women Following SSRI Switch

Por Binkhorst, Lisette, Bannink, Marjolein, de Bruijn, Peter, Ruit, Jan, Droogendijk, Helga, van Alphen, Robbert J., den Boer, Tilly D., Lam, Mei Ho, Jager, Agnes, van Gelder, Teun, Mathijssen, Ron H. J.
Publicado no Clin Pharmacokinet (2015)

Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study

Por Konings, Inge R. H. M., Sleijfer, Stefan, Mathijssen, Ron H. J., de Bruijn, Peter, Ghobadi Moghaddam-Helmantel, Inge M., van Dam, Linda M., Wiemer, Erik A. C., Verweij, Jaap, Loos, Walter J.
Publicado em 2010

4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes

Por de Graan, Anne-Joy M, Sparreboom, Alex, de Bruijn, Peter, de Jonge, Evert, van der Holt, Bronno, Wiemer, Erik A C, Verweij, Jaap, Mathijssen, Ron H J, van Schaik, Ron H N
Publicado no Br J Clin Pharmacol (2015)

Relationship Between Sunitinib Pharmacokinetics and Administration Time: Preclinical and Clinical Evidence

Por Kloth, Jacqueline S. L., Binkhorst, Lisette, de Wit, Annelieke S., de Bruijn, Peter, Hamberg, Paul, Lam, Mei H., Burger, Herman, Chaves, Ines, Wiemer, Erik A. C., van der Horst, Gijsbertus T. J., Mathijssen, Ron H. J.
Publicado no Clin Pharmacokinet (2015)

CYP3A4*22 genotype and systemic exposure affect paclitaxel-induced neurotoxicity

Por de Graan, Anne-Joy M., Elens, Laure, Sprowl, Jason A., Sparreboom, Alex, Friberg, Lena E., van der Holt, Bronno, de Raaf, Pleun J., de Bruijn, Peter, Engels, Frederike K., Eskens, Ferry A.L.M., Wiemer, Erik A.C., Verweij, Jaap, Mathijssen, Ron H.J., van Schaik, Ron H.N.
Publicado em 2013

Circadian variation in tamoxifen pharmacokinetics in mice and breast cancer patients

Por Binkhorst, Lisette, Kloth, Jacqueline S. L., de Wit, Annelieke S., de Bruijn, Peter, Lam, Mei H., Chaves, Ines, Burger, Herman, van Alphen, Robbert J., Hamberg, Paul, van Schaik, Ron H. N., Jager, Agnes, Koch, Birgit C. P., Wiemer, Erik A. C., van Gelder, Teun, van der Horst, Gijsbertus T. J., Mathijssen, Ron H. J.
Publicado no Breast Cancer Res Treat (2015)

Influence of Polymorphic OATP1B-Type Carriers on the Disposition of Docetaxel

Por de Graan, Anne-Joy M., Lancaster, Cynthia S., Obaidat, Amanda, Hagenbuch, Bruno, Elens, Laure, Friberg, Lena E., de Bruijn, Peter, Hu, Shuiying, Gibson, Alice A., Bruun, Gitte H., Corydon, Thomas J., Mikkelsen, Torben S., Walker, Aisha L., Du, Guoqing, Loos, Walter J., van Schaik, Ron H. N., Baker, Sharyn D., Mathijssen, Ron H. J., Sparreboom, Alex
Publicado em 2012

Effectiveness and cost-effectiveness of early assisted discharge for Chronic Obstructive Pulmonary Disease exacerbations: the design of a randomised controlled trial

Por van der Pouw Anouschka, de Bruijn Peter J, van de Pas Brigitte, Demunck Dirk RAJ, Seezink Wiel, van Vliet Monique, Janssen Annet, van Litsenburg Walter, van Schayck Onno CP, Smeenk Frank WJM, Goossens Lucas MA, Utens Cecile MA, Retera Jeroen MAM, de Laat-Bierings Petra, van Eijsden Loes, Braken Maria, Eijsermans Riet, Rutten-van Mölken Maureen PMH
Publicado em 2010-10-01

Effectiveness and cost-effectiveness of early assisted discharge for Chronic Obstructive Pulmonary Disease exacerbations: the design of a randomised controlled trial

Por Utens, Cecile MA, Goossens, Lucas MA, Smeenk, Frank WJM, van Schayck, Onno CP, van Litsenburg, Walter, Janssen, Annet, van Vliet, Monique, Seezink, Wiel, Demunck, Dirk RAJ, van de Pas, Brigitte, de Bruijn, Peter J, van der Pouw, Anouschka, Retera, Jeroen MAM, de Laat-Bierings, Petra, van Eijsden, Loes, Braken, Maria, Eijsermans, Riet, Rutten-van Mölken, Maureen PMH
Publicado em 2010